BioArctic AB
Developing innovative drugs for neurodegenerative CNS disorders through advanced research.
Oversigt
- 100–199
- Medarbejdere
- 100–500mio SEK
- Omsætning
- 2000
- Grundlagt
Nøglebeslutningstagere
Oskar Bosson
VP, Head of IR & Communication
Lars Lannfelt
Board member
Anna-Lena Engwall
Board member
Mikael Moge
VP, Head of CMC
+16 flere kontakter i Funnelfeedr
Beskrivelse
BioArctic is a Swedish research-oriented biopharma company dedicated to revolutionizing treatments for neurodegenerative disorders. The organization focuses intensely on developing disease-modifying drugs for conditions such as Alzheimer’s disease, Parkinson’s disease, and ALS. They leverage 20 year...